GlassScriptPhysician profile
Bashar Yousif Sharma
NPI 1124472782
$29,568.75
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $589 · 2022: $1,296 · 2023: $935 · 2024: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $1,552 · Travel and Lodging: $1,033 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Food and Beverage | $1,551.65 |
| Travel and Lodging | $1,032.71 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26,578.49 | 2021-2024 | Resolution 360 Clip, Exalt Model D, Acquire |
| Abbvie INC. | $954.53 | 2021-2023 | Skyrizi |
| Gilead Sciences, INC. | $465.13 | 2021-2024 | Epclusa |
| Olympus Corporation of The Americas | $456.15 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $245.24 | 2021-2022 | |
| Micro-Tech Endoscopy USA, INC. | $233.45 | 2024 | |
| Janssen Biotech, INC. | $216.18 | 2023 | Stelara, Tremfya |
| Regeneron Healthcare Solutions, INC. | $191.74 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $114.62 | 2023 | Terlivaz |
| Fujifilm Healthcare Americas Corporation | $75.00 | 2023 | |
| Genzyme Corporation | $38.22 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.